Table 1.

Overview of the published studies on IVIG use including 10 or more patients

	Viard 1998 [2]	Trent 2003 [9]	Prins 2003 [3]	Campione 2003 [10]	Al-Mutairi 2004 [11]	Shortt 2004 [12]	Tan 2005 [13]	Stella 2007 [14]	Bachot 2003 [15]	Brown 2004 [16]	Schneck 2008 [17]
Study	PNC	RNC	RNC	PNC	PNC	RNC	RNC	RC	PNC	RNC	RC
Patients	10	24	48	10	12	16	12	23	34	24	75
Detach, %	39	44	45	49	58	65×	×	×	19	49	×
Dose IVIG, g/kg	3	4	3	2	2×5	2.8	2	×	2	1.6	1.9 (0.7×2.3)
Predicted mortality, %	×	33 (S)	×	35 (S)	×	38 (A)	×	35.8 (S)	24 (S)	28.6 (S)	25 (S)
Actual mortality, %	0	4	12	10	0	25	8	26	32	41.7	34

PNC = Prospective, noncontrolled; RNC = retrospective, noncontrolled; RC = retrospective, controlled; S = SCORTEN; A = APACHE.

^×Initial rash involving 65 ± 29% TBSA.